Procaps Group S A (PROCF) Return on Assets ROA from the fourth quarter of 2023 to fourth quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Dec 31 2023 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Procaps Group S a   (PROCF)


Procaps Group S A 's ROA from the fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Procaps Group S A 's ROA in the fourth quarter of 2023?
Procaps Group S a achieved a return on average assets (ROA) of 11.62 % in its fourth quarter of 2023, this is above PROCF's average return on assets of 8.46%.
Procaps Group S A assets over the 12 months ending in its fourth quarter of 2023 are valued at $579 million

ROA has improved compared to 11.38% in the third quarter of 2023, due to net income growth.

However, within the Healthcare sector 96 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2023 from to 892.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2023)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Total Assets Change -26.44 % 8.03 % 2.68 % 53.77 % 2.68 %
Y / Y Net Income Change -5.16 % - - - -
Net Income (TTM) in million 67 69 69 36 36
Return On Assets (TTM) 11.62 % 11.38 % 11.65 % 6 % 6.75 %
PROCF's Total Ranking # 892 # # # #
Total Assets (TTM) in million 348 749 472 748 472
Seq. Total Assets Change -53.57 % 58.45 % -36.85 % 58.36 % -31.82 %
Seq. Net Income Change - - - - -

PROCF's 5 Years Annual ROA >> Back to PROCF Management Effectiveness >> Compare PROCF ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 38
Sector # 97
Overall # 876

Return On Assets Statistics
High Average Low
8.46 %
8.46 %
8.46 %
(Dec 31 2023)  





Financial Statements
Procaps Group S A 's Assets $ 348 million PROCF's Balance sheet
Procaps Group S A 's Income $ 40 million Quarterly PROCF's Income Statement
PROCF's Income by Division See PROCF's Income by Division



Annual Return On Assets (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2020)
FY 2021
FY
Y / Y Total Assets Change -53.57 % 8.03 % 81.61 % - -
Total Assets in million 348 749 693 382 0
Y / Y Net Income Change - 11.67 % - - -
Net Income in million -68 40 36 -107 0
Annual Return On Assets -19.65 % 5.39 % 5.21 % -28.04 % -

PROCF's 5 Years Annual ROA >> Back to PROCF Management Effectiveness >> Compare PROCF ROA to its Competitors



More Return On Assets Ratios
PROCF's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PROCF's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PROCF's Competitors
Subscribers only: Roa for Procaps Group S A 's Suppliers
Subscribers only: Return On Assets for PROCF's Customers

You may also want to know
PROCF's Roi PROCF's Inventory Turnover Ratio PROCF's Growth Rates PROCF's Dividend Comparisons
PROCF's Profitability Ratios PROCF's Asset Turnover Ratio PROCF's Dividend Growth
PROCF's Roe PROCF's Valuation Ratios PROCF's Financial Strength Ratios PROCF's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2023, within Healthcare Sector ROA
Cv Sciences Inc   30.87 %
Idexx Laboratories Inc  28.11 %
Semler Scientific inc   27.15 %
Alpha Tau Medical Ltd  26.91 %
Elite Pharmaceuticals Inc   26.72 %
Nrc Health  24.27 %
Mettler toledo International Inc   23.50 %
Inmode Ltd   22.93 %
Lantheus Holdings Inc   22.30 %
Iradimed Corporation  20.43 %
Johnson and Johnson  19.49 %
Earth Science Tech Inc   19.26 %
Medpace Holdings Inc   19.02 %
Lite Strategy Inc   18.26 %
Spero Therapeutics Inc   18.21 %
Corcept Therapeutics Inc  17.90 %
Chemed Corporation  17.68 %
Cardiff Lexington Corporation  17.40 %
Vertex Pharmaceuticals Inc  17.28 %
Harmony Biosciences Holdings inc   16.82 %
Zoetis Inc   16.75 %
Alkermes Plc   16.69 %
Waters Corporation  16.63 %
Catalyst Pharmaceuticals Inc   16.47 %
West Pharmaceutical Services Inc   15.85 %
Halozyme Therapeutics Inc   15.78 %
Edwards Lifesciences Corporation  15.38 %
Innoviva Inc   15.36 %
Exelixis Inc   15.25 %
Ladrx Corporation  15.13 %

Date modified: 2026-09-02T18:50:17+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.